John R. Moore Insider Profile

4 Followers
John R. Moore, VP & GC at Array Biopharma, holds 3.25K shares in Edgewise Therapeutics (Ticker: EWTX), holds 42.06K shares in Array Technologies (Ticker: ARRY), holds 42.26K shares in Array Biopharma (Ticker: ~ARRY).
tipranks
John R. Moore

John R. Moore
Array Biopharma (~ARRY)
VP & GC

Ranked #88,526 out of 99,218 Corporate Insiders

Profitable Transactions

25%
2 out of 8 Profitable Transactions

Average Return

-27.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$392K
71.82%
28.18%
A breakdown of John R. Moore's holdings

Insider Roles

Array Technologies
(ARRY)
VP, General Counsel
Edgewise Therapeutics
(EWTX)
GC
Roles that John R. Moore holds in companies

Most Profitable Insider Trade

Stock:
Edgewise Therapeutics
(EWTX)
Rating:Informative Sell
Date:Aug 05, 2022 - Aug 05, 2023
Return:+37.70%
The most profitable trade made by John R. Moore

John R. Moore's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
~ARRY
Array Biopharma
Apr 05, 2016
Uninformative Sell
7.51K
$2.02M
Edgewise Therapeutics
Sep 24, 2024
GC
Uninformative Buy
50.35K
$110.57K
Array Technologies
Apr 04, 2017
VP, General Counsel
Uninformative Buy
20.65K
$281.83K
List of latest transactions for each holding click on a transaction to see John R. Moore's performance on stock

John R. Moore insider profile FAQ

What is the percentage of profitable transactions made by John R. Moore?
The percentage of profitable transactions made by John R. Moore is 25%.
    What is the average return per transaction made by John R. Moore?
    The average return per transaction made by John R. Moore is -27.10%.
      What stocks does John R. Moore hold?
      John R. Moore holds: ~ARRY, EWTX, ARRY stocks.
        What was John R. Moore’s latest transaction?
        John R. Moore latest transaction was an Uninformative Buy of $50.35K.
          What was John R. Moore's most profitable transaction?
          John R. Moore’s most profitable transaction was an Informative Sell of EWTX stock on August 5, 2022. The return on the trade was 37.70%.
            What is John R. Moore's role in Array Biopharma?
            John R. Moore's role in Array Biopharma is VP & GC.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.